This Post-Activity Assessment includes 10 questions.
0 of 10 questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
A score of 70% or better is required to complete the evaluation and application for credit.
Latest advances in immunotherapy for blood cancers include all except:
CAR T cell therapy activity includes:
CD19 is an ideal cell surface tumor target in B-cell malignancies because CD19:
CAR T patients are given lymphodepleting chemotherapy:
The current indications for tisagenlecleucel include:
B-cell maturation antigen (BCMA) CD269 is uniformly expressed by immunohistochemistry on what percentage of cases of multiple myeloma?
For a patient treated with CAR T-cell therapy who experiences fever and chills but remains normotensive, treatment may include:
The upfront cost of purchasing the CAR T-cell product at the price point is the responsibility of:
Fever associated with Cytokine Release Syndrome (CRS) is characterized by all except:
Which of the following statements are accurate regarding CAR T-cell therapy? (Select one or more choices)